Visible Genetics, Bayer deal

BAYG's Bayer Diagnostics business group (Tarrytown, N.Y.) completed its previously announced acquisition of VGIN for $61.4 million based on 40.9 million shares at $1.50 (see BioCentury, July 29). ...